Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Biomed Mater Res B Appl Biomater ; 106(2): 649-658, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28276202

RESUMEN

Bone defects created after curettage of benign bone tumors are customarily filled with solid poly(methyl methacrylate) (PMMA) or other bone substitutes. In this study, we depicted a porous PMMA-based cement (produced by mixing sodium bicarbonate and citric acid) and evaluated the prospect of its clinic application. Cement samples were characterized by high-performance liquid chromatography (HPLC) coupled to mass spectrometry and its cytotoxicity evaluated in fibroblast cultures. Implantation in rabbits allowed the histologic analysis of bone, kidneys, and liver for toxicity and coagulation tests, and MRI images for hemostasis evaluation. Osseointegration was analyzed through radiography, microtomography (micro-CT), SEM, and histology of sheep specimens. Rabbit specimens were analyzed 1, 4, and 7 days after implantation of porous or solid bone cement in 6.0 mm femoral defects. Sheep specimens were analyzed 3 and 6 months after implantation or not of porous or solid cement in 15.0 mm subchondral tibial defects. The production process did not release any detectable toxic substance but slightly reduced fibroblast proliferation in vitro. Until 7 days after surgery, no local or systemic alterations could be detected in histology, or hematoma formation in histology or MRI. Sheep implants showed 6 mm linear ingrowth from the bone-cement interface and 20% bone ingrowth considering the whole defect area. Radiography, micro-CT, SEM, and histology confirmed these findings. We conclude that our porous PMMA-based cement is an attractive alternative treatment for bone defect filling that combines osseointegration and early weight bearing. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 649-658, 2018.


Asunto(s)
Cementos para Huesos/farmacología , Sustitutos de Huesos/farmacología , Oseointegración/efectos de los fármacos , Polimetil Metacrilato/farmacología , Animales , Cementos para Huesos/química , Sustitutos de Huesos/química , Trasplante Óseo , Línea Celular , Supervivencia Celular/efectos de los fármacos , Ácido Cítrico/química , Ácido Cítrico/farmacología , Modelos Animales de Enfermedad , Humanos , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Ratones , Células 3T3 NIH , Polimetil Metacrilato/química , Porosidad , Conejos , Ovinos , Bicarbonato de Sodio/química , Bicarbonato de Sodio/farmacología
2.
Phytochemistry ; 96: 418-22, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24210092

RESUMEN

LC-DAD-MS/MS analysis of the Brazilian medicinal plant Bidens gardneri Bak. (Asteraceae) results in identification of eleven phenolic compounds. HRESIMS, MS/MS and UV data analyses, with phytochemicals isolation guided by MS data, results in flavanones-(-)-4'-methoxy-7-O-ß-D-glucopyranosyl-8,3'-dihydroxyflavanone; (-)-7-O-(6″-E-p-coumaroyl)-ß-D-glucopyranosyl-8,3',4'-trihydroxyflavanone; and (-)-4'-methoxy-7-O-(6″-acetyl)-ß-D-glucopyranosyl-8,3'-dihydroxyflavanone being identified-together with four known compounds. The absolute configurations of two of the flavanones were determined as 2S via circular dichroism.


Asunto(s)
Bidens/química , Flavanonas/aislamiento & purificación , Glicósidos/aislamiento & purificación , Brasil , Dicroismo Circular , Flavanonas/química , Glicósidos/química , Estructura Molecular , Fenoles/química , Fenoles/aislamiento & purificación , Plantas Medicinales/química
3.
Planta Med ; 78(18): 1939-41, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23150073

RESUMEN

Tetrahydrofuran lignans represent a well-known group of phenolic compounds capable of acting as antiparasitic agents. In the search for new medicines for the treatment of Chagas disease, one promising compound is grandisin which has shown significant activity on trypomastigote forms of Trypanosoma cruzi. In this work, the in vitro metabolism of grandisin was studied in the pig cecum model and by biomimetic phase I reactions, aiming at an ensuing a preclinical pharmacokinetic investigation. Although grandisin exhibited no metabolization by the pig microbiota, one putative metabolite was formed in a biomimetic model using Jacobsen catalyst. The putative metabolite was tested against T. cruzi revealing loss of activity in comparison to grandisin.


Asunto(s)
Antiprotozoarios/farmacocinética , Enfermedad de Chagas/tratamiento farmacológico , Furanos/metabolismo , Furanos/farmacología , Lignanos/metabolismo , Lignanos/farmacología , Piper/química , Extractos Vegetales/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Antiprotozoarios/química , Ciego/parasitología , Estructura Molecular , Extractos Vegetales/química , Porcinos
4.
Anal Bioanal Chem ; 404(1): 257-66, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22644152

RESUMEN

An high performance liquid chromatography (HPLC) method for the enantioselective determination of donepezil (DPZ), 5-O-desmethyl donepezil (5-ODD), and 6-O-desmethyl donepezil (6-ODD) in Czapek culture medium to be applied to biotransformation studies with fungi is described for the first time. The HPLC analysis was carried out using a Chiralpak AD-H column with hexane/ethanol/methanol (75:20:5, v/v/v) plus 0.3 % triethylamine as mobile phase and UV detection at 270 nm. Sample preparation was carried out by liquid-liquid extraction using ethyl acetate as extractor solvent. The method was linear over the concentration range of 100-10,000 ng mL(-1) for each enantiomer of DPZ (r ≥ 0.9985) and of 100-5,000 ng mL(-1) for each enantiomer of 5-ODD (r ≥ 0.9977) and 6-ODD (r ≥ 0.9951). Within-day and between-day precision and accuracy evaluated by relative standard deviations and relative errors, respectively, were lower than 15 % for all analytes. The validated method was used to assess DPZ biotransformation by the fungi Beauveria bassiana American Type Culture Collection (ATCC) 7159 and Cunninghamella elegans ATCC 10028B. Using the fungus B. bassiana ATCC 7159, a predominant formation of (R)-5-ODD was observed while for the fungus C. elegans ATCC 10028B, DPZ was biotransformed to (R)-6-ODD with an enantiomeric excess of 100 %.


Asunto(s)
Beauveria/metabolismo , Cromatografía Líquida de Alta Presión/métodos , Cunninghamella/metabolismo , Indanos/metabolismo , Piperidinas/metabolismo , Biotransformación , Medios de Cultivo/metabolismo , Donepezilo , Indanos/química , Estructura Molecular , Piperidinas/química , Estereoisomerismo
5.
Electrophoresis ; 31(9): 1521-8, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20376815

RESUMEN

A CE method was developed and validated for the stereoselective determination of midodrine and desglymidodrine in Czapek culture medium to be applied to a stereoselective biotransformation study employing endophytic fungi. The electrophoretic analyses were performed using an uncoated fused-silica capillary and 70 mmol/L sodium acetate buffer solution (pH 5.0) containing 30 mmol/L heptakis (2, 3, 6-tri-O-methyl)-beta-CD as running electrolyte. The applied voltage and temperature used were 15 kV and 15 degrees C, respectively. The UV detector was set at 200 nm. The sample preparation was carried out by liquid-liquid extraction using ethyl acetate as extractor solvent. The method was linear over the concentration range of 0.1-12 microg/mL for each enantiomer of midodrine and desglymidodrine (r> or =0.9975). Within-day and between-day precision and accuracy evaluated by RSDs and relative errors, respectively, were lower than 15% for all analytes. The method proved to be robust by a fractional factorial design evaluation. The validated method was used to assess the midodrine biotransformation to desglymidodrine by the fungus Phomopsis sp. (TD2), which biotransformed 1.1% of (-)-midodrine to (-)-desglymidodrine and 6.1% of (+)-midodrine to (+)-desglymidodrine.


Asunto(s)
Ascomicetos/química , Electroforesis Capilar/métodos , Midodrina/análogos & derivados , Midodrina/análisis , Ascomicetos/metabolismo , Asteraceae/microbiología , Medios de Cultivo , Modelos Lineales , Midodrina/química , Midodrina/metabolismo , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Estereoisomerismo , Temperatura
6.
J Pharm Biomed Anal ; 52(5): 796-801, 2010 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-20376912

RESUMEN

Thioridazine (THD) is a commonly prescribed phenotiazine neuroleptic drug, which is extensively biotransformed in the organism producing as main metabolites sulfoxides and a sulfone by sulfur oxidation. Significant differences have been observed in the activity of the THD enantiomers as well as for its main metabolites, and enantioselectivity phenomena have been proved in the metabolic pathway. Here the assignment of the absolute configuration at the sulfur atom of enantiomeric THD-2-sulfoxide (THD-2-SO) has been carried out by circular dichroism (CD) spectroscopy. The stereoisomers were separated by HPLC on Chiralpak AS column, recording the CD spectra for the two collected enantiomeric fractions. The theoretical electronic CD spectrum has been obtained by the TDDFT/B3LYP/6-31G*, as Boltzmann averaging of the contributions calculated for the most stable conformations of the drug. The comparison of the simulated and experimental spectra allowed the absolute configuration at the sulfur atom of the four THD-2-SO stereoisomers to be assigned. The developed method should be useful for a reliable correlation between stereochemistry and activity and/or toxicity.


Asunto(s)
Tioridazina/análogos & derivados , Tioridazina/química , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Modelos Moleculares , Conformación Molecular , Estereoisomerismo , Tioridazina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...